These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 7004552)
1. [Control of leprosy: fantasies and possibilities]. Browne SG Bull Mem Acad R Med Belg; 1980; 135(3):208-18. PubMed ID: 7004552 [No Abstract] [Full Text] [Related]
2. Treatment of sulphone resistant leprosy--a review of sixty one cases. Seshadri PS; Ravi NT Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123 [No Abstract] [Full Text] [Related]
3. WHO global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010). World Health Organization Indian J Lepr; 2006; 78(1):7-31. PubMed ID: 16646281 [No Abstract] [Full Text] [Related]
4. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs. Almeida JG Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367 [No Abstract] [Full Text] [Related]
5. Time to define leprosy elimination as zero leprosy transmission? Smith CS; Aerts A; Kita E; Virmond M Lancet Infect Dis; 2016 Apr; 16(4):398-9. PubMed ID: 27036335 [No Abstract] [Full Text] [Related]
6. The need for new drugs in the treatment and control of leprosy. Baker RJ Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):78-97. PubMed ID: 2181046 [No Abstract] [Full Text] [Related]
7. WHO regional strategy for sustaining leprosy services and further reducing the burden of leprosy, 2006-2010. WHO Regional Office for South-East Asia Indian J Lepr; 2006; 78(1):33-47. PubMed ID: 16646282 [No Abstract] [Full Text] [Related]
8. Chemotherapy of leprosy for control programmes. World Health Organ Tech Rep Ser; 1982; 675():1-33. PubMed ID: 6806990 [No Abstract] [Full Text] [Related]
9. Epidemiology of leprosy in relation to control. Report of a WHO Study Group. World Health Organ Tech Rep Ser; 1985; 716():1-60. PubMed ID: 3925646 [No Abstract] [Full Text] [Related]
10. Leprosy at a turning point? Harboe M Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095 [No Abstract] [Full Text] [Related]
11. [Research in developing countries: will leprosy vaccine be produced in Nepal?]. Kurlberg G Nord Med; 1990; 105(12):338-9. PubMed ID: 2270200 [TBL] [Abstract][Full Text] [Related]
12. Multidrug therapy--the pathway for global leprosy elimination. al-Qubati Y; al-Kubati AS Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482 [TBL] [Abstract][Full Text] [Related]
13. Progress in the chemotherapy of leprosy. Grosset JH Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266 [No Abstract] [Full Text] [Related]
14. WHO Expert Committee on Leprosy. World Health Organ Tech Rep Ser; 1988; 768():1-51. PubMed ID: 3140498 [No Abstract] [Full Text] [Related]
16. A overview of ocular leprosy after 2 decades of multidrug therapy. Lewallen S; Courtright P Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278 [No Abstract] [Full Text] [Related]
17. Taking home lessons from the 15th International Leprosy Congress. Lechat MF Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):562-6. PubMed ID: 10347572 [No Abstract] [Full Text] [Related]
19. An update on the diagnosis and treatment of leprosy. Moschella SL J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986 [No Abstract] [Full Text] [Related]
20. The debate over leprosy elimination versus sustainability of leprosy services. Indian J Lepr; 2005; 77(4):299-304. PubMed ID: 16465825 [No Abstract] [Full Text] [Related] [Next] [New Search]